中国儿童全血C反应蛋白检测系统性能评价标准建立专家共识

2021-12-28 中国妇幼保健协会临床诊断与实验医学分会 检验医学

C反应蛋白(CRP)是感染性疾病的辅助诊断指标之一。测定CRP的标本类型已不局限于血清,全血CRP检测在各级医疗机构,特别是妇幼保健机构、儿童医院已广泛开展。

中文标题:

中国儿童全血C反应蛋白检测系统性能评价标准建立专家共识

发布日期:

2021-12-28

简要介绍:

C反应蛋白(CRP)是感染性疾病的辅助诊断指标之一。测定CRP的标本类型已不局限于血清,全血CRP检测在各级医疗机构,特别是妇幼保健机构、儿童医院已广泛开展。全血CRP检测设备品牌众多,但尚无相关检测系统的性能评价标准;中国妇幼保健协会临床诊断与实验医学分会根据26家妇幼保健机构和儿童医院的研究结果,制定了“中国儿童全血C反应蛋白检测系统性能评价标准建立专家共识”,旨在通过分析全血CRP检测系统的性能状况,结合临床需求、生物学变异、行业标准,进一步明确全血CRP检测系统性能评价要求,以保证检测质量。

相关资料下载:
[AttachmentFileName(sort=1, fileName=中国儿童全血C反应蛋白检测系统性能评价标准建立专家共识.pdf)] GetToolGuiderByIdResponse(projectId=1, id=71f781c002310373, title=中国儿童全血C反应蛋白检测系统性能评价标准建立专家共识, enTitle=, guiderFrom=检验医学, authorId=0, author=, summary=C反应蛋白(CRP)是感染性疾病的辅助诊断指标之一。测定CRP的标本类型已不局限于血清,全血CRP检测在各级医疗机构,特别是妇幼保健机构、儿童医院已广泛开展。, cover=https://img.medsci.cn/202214/1641278921264_5579292.jpg, journalId=0, articlesId=null, associationId=2033, associationName=中国妇幼保健协会临床诊断与实验医学分会, associationIntro=中国妇幼保健协会临床诊断与实验医学分会, copyright=0, guiderPublishedTime=Tue Dec 28 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">C反应蛋白(CRP)是感染性疾病的辅助诊断指标之一。测定CRP的标本类型已不局限于血清,全</span><span style="color: #373737;">血CRP检测在各级医疗机构,特别是妇幼保健机构、儿童医院已广泛开展。全血CRP检测设备品牌众多,但尚无相关检测系统的性能评价标准;中国妇幼保健协会临床诊断与实验医学分会根据26家妇幼保健机构和儿童医院的研究结果,制定了&ldquo;中国儿童全血C反应蛋白检测系统性能评价标准建立专家共识&rdquo;,旨在通过分析全血CRP检测系统的性能状况,结合临床需求、生物学变异、行业标准,进一步明确全血CRP检测系统性能评价要求,以保证检测质量。</span></p>, tagList=[TagDto(tagId=6353, tagName=C反应蛋白), TagDto(tagId=115807, tagName=临床血液学检验), TagDto(tagId=120821, tagName=全血CRP检测)], categoryList=[CategoryDto(categoryId=69, categoryName=检验病理, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=6353, guiderKeyword=C反应蛋白, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=18708, appHits=87, showAppHits=0, pcHits=963, showPcHits=18621, likes=0, shares=21, comments=6, approvalStatus=1, publishedTime=Tue Jan 04 14:47:43 CST 2022, publishedTimeString=2021-12-28, pcVisible=1, appVisible=1, editorId=5579292, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=FUNNYMAN, createdTime=Tue Jan 04 14:50:14 CST 2022, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Fri Jan 05 13:52:11 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=中国儿童全血C反应蛋白检测系统性能评价标准建立专家共识.pdf)])
中国儿童全血C反应蛋白检测系统性能评价标准建立专家共识.pdf
下载请点击:
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2103089, encodeId=969d2103089fb, content=赞👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6418434917, createdName=ms2000001381106517, createdTime=Mon Nov 28 16:28:12 CST 2022, time=2022-11-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1235231, encodeId=0adc12352315d, content=棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=31662496429, createdName=1248c8b2m12(暂无昵称), createdTime=Thu Jul 28 10:01:13 CST 2022, time=2022-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200445, encodeId=991e1200445da, content=专家共识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220223/22f5137b1e464c9ebdb5cf908caa3b81/8ff036c799ee492a9c61d22d0a37af15.jpg, createdBy=7d666510826, createdName=ms7000000141352835, createdTime=Tue Mar 08 07:21:04 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180755, encodeId=0a5a1180e554d, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Wed Jan 05 07:33:18 CST 2022, time=2022-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180754, encodeId=9f6a1180e54b9, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Wed Jan 05 07:33:08 CST 2022, time=2022-01-05, status=1, ipAttribution=)]
    2022-11-28 ms2000001381106517 来自山东省

    赞👍

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2103089, encodeId=969d2103089fb, content=赞👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6418434917, createdName=ms2000001381106517, createdTime=Mon Nov 28 16:28:12 CST 2022, time=2022-11-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1235231, encodeId=0adc12352315d, content=棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=31662496429, createdName=1248c8b2m12(暂无昵称), createdTime=Thu Jul 28 10:01:13 CST 2022, time=2022-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200445, encodeId=991e1200445da, content=专家共识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220223/22f5137b1e464c9ebdb5cf908caa3b81/8ff036c799ee492a9c61d22d0a37af15.jpg, createdBy=7d666510826, createdName=ms7000000141352835, createdTime=Tue Mar 08 07:21:04 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180755, encodeId=0a5a1180e554d, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Wed Jan 05 07:33:18 CST 2022, time=2022-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180754, encodeId=9f6a1180e54b9, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Wed Jan 05 07:33:08 CST 2022, time=2022-01-05, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2103089, encodeId=969d2103089fb, content=赞👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6418434917, createdName=ms2000001381106517, createdTime=Mon Nov 28 16:28:12 CST 2022, time=2022-11-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1235231, encodeId=0adc12352315d, content=棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=31662496429, createdName=1248c8b2m12(暂无昵称), createdTime=Thu Jul 28 10:01:13 CST 2022, time=2022-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200445, encodeId=991e1200445da, content=专家共识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220223/22f5137b1e464c9ebdb5cf908caa3b81/8ff036c799ee492a9c61d22d0a37af15.jpg, createdBy=7d666510826, createdName=ms7000000141352835, createdTime=Tue Mar 08 07:21:04 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180755, encodeId=0a5a1180e554d, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Wed Jan 05 07:33:18 CST 2022, time=2022-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180754, encodeId=9f6a1180e54b9, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Wed Jan 05 07:33:08 CST 2022, time=2022-01-05, status=1, ipAttribution=)]
    2022-03-08 ms7000000141352835

    专家共识

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2103089, encodeId=969d2103089fb, content=赞👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6418434917, createdName=ms2000001381106517, createdTime=Mon Nov 28 16:28:12 CST 2022, time=2022-11-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1235231, encodeId=0adc12352315d, content=棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=31662496429, createdName=1248c8b2m12(暂无昵称), createdTime=Thu Jul 28 10:01:13 CST 2022, time=2022-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200445, encodeId=991e1200445da, content=专家共识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220223/22f5137b1e464c9ebdb5cf908caa3b81/8ff036c799ee492a9c61d22d0a37af15.jpg, createdBy=7d666510826, createdName=ms7000000141352835, createdTime=Tue Mar 08 07:21:04 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180755, encodeId=0a5a1180e554d, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Wed Jan 05 07:33:18 CST 2022, time=2022-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180754, encodeId=9f6a1180e54b9, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Wed Jan 05 07:33:08 CST 2022, time=2022-01-05, status=1, ipAttribution=)]
    2022-01-05 微探

    学习学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2103089, encodeId=969d2103089fb, content=赞👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6418434917, createdName=ms2000001381106517, createdTime=Mon Nov 28 16:28:12 CST 2022, time=2022-11-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1235231, encodeId=0adc12352315d, content=棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=31662496429, createdName=1248c8b2m12(暂无昵称), createdTime=Thu Jul 28 10:01:13 CST 2022, time=2022-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200445, encodeId=991e1200445da, content=专家共识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220223/22f5137b1e464c9ebdb5cf908caa3b81/8ff036c799ee492a9c61d22d0a37af15.jpg, createdBy=7d666510826, createdName=ms7000000141352835, createdTime=Tue Mar 08 07:21:04 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180755, encodeId=0a5a1180e554d, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Wed Jan 05 07:33:18 CST 2022, time=2022-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180754, encodeId=9f6a1180e54b9, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Wed Jan 05 07:33:08 CST 2022, time=2022-01-05, status=1, ipAttribution=)]
    2022-01-05 微探

    学习学习

    0